Skip to content
Search

Latest Stories

How to build a profitable medical aesthetics business

As we come close to stepping out of a series of lockdowns and into a new age, getting Botox will be as regular as getting a haircut, says award-winning pharmacist Amish Patel…

Back in 2016, I embarked on my adventure into medical aesthetics, and created Intrigue Cosmetic Clinic. At the time, I don’t think I truly realized where this would take me and the reach that the clinic would have.


Social media, the digital age and people living longer have all led to people taking a greater interest in appearance. In 2015, statistics showed that six in 10 people dislike something about their appearance, and 70 per cent of those would do something about it.

In 2015 alone, there was a 45 per cent increase in use of Botox and dermal fi llers, and this number has continued to grow ever since. However, there is unfortunately a lack of regulation in this industry, meaning absolutely anyone can pick up a syringe and inject someone.

High returns

The number of adverts which entice non-professionals into the industry promising 6 figure profits is scary. This has all lead to a continued increase in ‘botched’ procedures.

Other than Harley Street, there were few places on the high street offering medical aesthetics services. Seeing this gap lead me in my quest to provide a safe and medical environment for people to receive non-surgical procedures. The clinic also upholds my values and unwavering standards. I am an utter perfectionist in every respect.

I started the clinic with a small ring fenced budget of £20,000. Within nine months, the clinic was breaking even on a monthly basis. From there, I continued to re-invest into the business, whether in marketing or continual training, to ensure I always remain at the forefront of the industry and non-surgical cosmetic trends.

Setting up the clinic was certainly not without its challenges. Coming from a pharmaceutical background into the aesthetics industry when I did was still relatively novel.

The simplest of things such as finding insurance and opening up accounts with wholesalers was difficult as there were few training providers, fewer insurance companies willing to insure pharmacists, and wholesalers who wouldn’t accept pharmacies to open an account.

Nose 1 People are taking a greater interest in their appearance

Standing out

The biggest challenge has been proving myself and standing out from the crowd in what is generally a saturated market. However, I used my pharmacy background to my advantage with numerous transferrable medical skills; consultation, assessment, consent, medical history evaluation and anatomical examinations.

I overcame all the challenges by believing in myself, investing in myself, and remembering that word of mouth is the most powerful marketing tool. Now I have a diverse client base, ranging from well-known faced from the world of modelling, sports and TV, city high fl yers wanting to present in the boardroom in confidence, to those simply wanting to turn back the clock and look naturally refreshed and rejuvenated.

On average, the majority of clients will travel 45 minutes to the clinic, but I have also seen those coming from abroad as further afield as Dubai. I will now be developing myself as a trainer in facial aesthetics.

This last year presented new challenges. Due to the Coronavirus pandemic, following government guidelines, I was unable to offer any treatments. In the last 12 months, the clinic was open for only four months.

Clinic

Zoom effect

However, with all new challenges comes new opportunities. Just prior to lockdown, we had begun offering virtual consultations. Once the lockdown was announced, I spent time promoting virtual consultations for skincare advice, after which I would be able to prescribe and post out treatments to the patients.

I found this gave me a whole new reach of patients, as not many clinics were offering such a service. Common concerns ranged from general anti-ageing advice to acne and hyperpigmentation treatment.

As lockdowns eased, we continued to offer virtual consultations for prospective new patients seeking treatments, as this then saved a lot of clinic time once we re-opened for face-to-face treatments.

The pandemic challenged almost all industries and business to find new ways of working, with ‘you’re on mute’ probably now one of the most said sentences on a daily basis as everyone moves to Zoom. In the aesthetic industry, this has seen what many describe as the ‘Zoom effect’.

People are analysing their appearance more than ever due to how they see themselves on screen. This will certainly expand the number of people seeking treatments to its highest level ever. As we come close to stepping out of lockdown and into a new age, I believe getting Botox will be as regular as getting a haircut.

To anyone looking to get into medical aesthetics, there was never a better time than now. I welcome anyone to contact me for advice on getting trained, setting up and getting started.

 Amish Patel is the founder of Intrigue Cosmetic Clinic.

More For You

How to leverage data to drive pharmacy growth

Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy.

Pharmacy challenges: How data can help spot the ‘elephant in the room’

Adopting new technologies is vital for moving pharmacy forward — but are you fully harnessing the data these tools generate?

“Being able to utilise, manage, and interpret the data these technologies provide can help add more value to your business,” said Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy, while speaking at the recent Pharmacy Business Conference.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Support for generic medicines manufacturers key to affordable healthcare- Teva UK director

Teva UK sounds alarm on accelerating consolidation of critical generic medicines

Photo credit: gettyimages

Exclusive: Teva UK calls for inclusion of generic manufacturers in policy talks

A healthy and vibrant generics marketplace supports not only patients but also contributes billions of pounds in savings to the drugs bill. However, growing pressures on generic medicine manufacturers could threaten this vital part of the healthcare ecosystem, warns Ryan Ruscoe, senior director of generics and OTC at Teva UK.

Speaking exclusively to Pharmacy Business, Ruscoe stressed the urgent need to address supply chain vulnerabilities, particularly for critical generic medicines.

Keep ReadingShow less